Agilent Technologies and Chungnam National University Collaborate to Further Glycomics Research

Agilent Technologies Inc. (NYSE: A) and Chungnam National University today announced an agreement to develop new applications, methods, technologies and software tools in the field of glycomics, the study of complex sugars. The university aims to identify and develop biomarkers for diseases such as cancer, leading to development of therapeutic antibody products.

Source: Agilent